InformationTorcetrapib Torcetrapib (CP-529414) is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.In vitroTorcetrapib dose-dependently increases aldosterone release from H295R cells after either 24 or 48 h
InformationTorcetrapib Torcetrapib (CP-529414) is a CETP inhibitor with IC50 of 37 nM, elevates HDL-C and reduces nonHDL-C in plasma. Phase 3.In vitroTorcetrapib dose-dependently increases aldosterone release from H295R cells after either 24 or 48 h